Kemin Health Europe has announced the European launch of its hunger-busting ingredient Slendesta. The product, available in the US under the Satise brand, is the latest weight-management product to be put on the market amid claims it stimulates the hormones that regulate appetite. A potato extract containing proteinase inhibitor II (PI2), a protein naturally found in white potatoes, Slendesta stimulates the release of the appetite regulating hormone CCK, claimed the company.
A randomised, placebo- controlled, cross-over clinical study of 45 participants recently demonstrated that when Slendesta was taken before a meal, CCK levels increased and remained elevated for longer after the meal than they did in the placebo group, Kemin said.